Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Boland

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Molecular Cancer Therapeutics|October 3, 2019
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular CorrelatesUsha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
American Journal of Clinical Oncology|November 13, 2018
A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer PatientsWen Wee Ma, Hao Xie, Gerald Fetterly, et al.
Clinical Genitourinary Cancer|May 16, 2023
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional StudyCorbin J Eule, Junxiao Hu, Sulaiman Al-Saad, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Nature Reviews. Clinical Oncology|July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaperArvind Dasari, Van K Morris, Carmen J Allegra, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Molecular Cancer Therapeutics|October 3, 2019
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular CorrelatesUsha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
American Journal of Clinical Oncology|November 13, 2018
A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer PatientsWen Wee Ma, Hao Xie, Gerald Fetterly, et al.
Clinical Genitourinary Cancer|May 16, 2023
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional StudyCorbin J Eule, Junxiao Hu, Sulaiman Al-Saad, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Nature Reviews. Clinical Oncology|July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaperArvind Dasari, Van K Morris, Carmen J Allegra, et al.
Pageof 5